Pages that link to "Q84498340"

The following pages link to Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update (Q84498340):

Displaying 36 items.

• Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma (Q26772324) (← links)
• Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china (Q27003291) (← links)
• Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges (Q28272678) (← links)
• Liver masses: a clinical, radiologic, and pathologic perspective. (Q30403670) (← links)
• Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil (Q33428936) (← links)
• Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma (Q34072173) (← links)
• Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol. (Q34759365) (← links)
• Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography (Q35093299) (← links)
• Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging (Q35148664) (← links)
• Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib (Q35722941) (← links)
• Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization? (Q35915311) (← links)
• Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development (Q36033548) (← links)
• Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment (Q36423166) (← links)
• Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation (Q36561581) (← links)
• Surveillance and Diagnosis of Hepatocellular Carcinoma (Q36812480) (← links)
• Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C. (Q36927621) (← links)
• Active treatments are a rational approach for hepatocellular carcinoma in elderly patients (Q36975081) (← links)
• Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up (Q37000684) (← links)
• Delayed bronchobiliary fistula and cholangiolithiasis following percutaneous radio frequency ablation for hepatocellular carcinoma (Q37071284) (← links)
• Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm (Q37246463) (← links)
• Perspectives on using des-γ-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China (Q37584690) (← links)
• Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review (Q37920769) (← links)
• Prevention of recurrence after curative treatment for hepatocellular carcinoma (Q38070128) (← links)
• The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma (Q38401905) (← links)
• The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma (Q41153363) (← links)
• The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis (Q45070731) (← links)
• Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test (Q45247507) (← links)
• Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume (Q47631201) (← links)
• In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery (Q47661269) (← links)
• Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma (Q51736029) (← links)
• A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy. (Q52647720) (← links)
• FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function. (Q53627290) (← links)
• Effect of Age (over 75 Years) on Postoperative Complications and Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. (Q54537549) (← links)
• Usefulness of aspartate aminotransferase to platelet ratio index as a prognostic factor following hepatic resection for hepatocellular carcinoma (Q58798449) (← links)
• Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection (Q84183780) (← links)
• Value of shear wave elastography for predicting hepatocellular carcinoma and esophagogastric varices in patients with chronic liver disease (Q86714203) (← links)